… -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader … began trading on the Nasdaq Global Market on January … prospectus relating to the initial public offering may be obtained from: … Beta Bionics from the initial public offering, including the full exercise …

… announced the closing of its initial public offering of 15,000,000 units … 30, 2025 on the Nasdaq Global Market (“Nasdaq”) under the ticker … warrants will be traded on Nasdaq under the symbols “SVCC” … statement and prospectus for the IPO filed with the SEC. …

… growth, and JVSPAC Acquisition Corp. (NASDAQ: JVSA) ("JVSPAC"), a … final prospectus related to its initial public offering dated January 18, 2024. Additional … -registration-statement-ahead-of-planned-nasdaq-listing-302365730.html SOURCE Hotel101

… -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage … pricing of its upsized initial public offering of 8,750,000 … common stock at the initial public offering price, less underwriting discounts … begin trading on the Nasdaq Global Market on January …

… NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical- … the pricing of its initial public offering of 15,277,778 … begin trading on the Nasdaq Global Select Market under … common stock at the initial public offering price less underwriting discounts …

A week after the first IPO of the year was priced, … Inc. have begun trading on Nasdaq. Metsera (NASDAQ:MTSR) surged 47% on … .50 per share while Maze (NASDAQ:MAZE) barely budged, closing three … ;sexual function Obesity Small molecule IPO U.S.

… nearly 42% in a strong Nasdaq debut on Friday, valuing … 5 apiece, compared with the initial public offering price of $18. The strong … 18 apiece after downsizing its IPO. The company had initially marketed … their appetite for U.S. IPOs. However, analyst do not …

(Reuters) -Maze Therapeutics became the latest drug developer to list in New York on Friday, with its shares rising nearly 1% in their debut, giving the company a valuation of $690.37 million. The muted market reaction suggests investors caution persists …

… its formal listing on the Nasdaq market. [Image from … (Nasdaq:BBNX) has gone public after pricing a significantly upsized initial public offering (IPO … .4 million in the IPO. The Irvine, California-based … the IPO, Beta Bionics today began trading on the Nasdaq …

… begin trading on the Nasdaq Global Market on … prospectus relating to the initial public offering may be obtained from … existing investors at the initial public offering price of $17. … Beta Bionics from the initial public offering and the concurrent private …